IP Library Granted Patent US 10,758,239
Granted Patent B2
US 10,758,239 · App. 15/358,483 · Granted Sep 1, 2020

Methods and devices for passive residual lung volume reduction and functional lung volume expansion

Inventors: Nikolai Aljuri (Hillsborough, CA); Rodney C. Perkins (Woodside, CA); Niyazi Beyhan (Santa Clara, CA)
Assignee: Pulmonx Corporation
A61B17/12104A61B5/055A61B5/08A61B5/085A61B5/0813A61B5/6853A61B6/03A61B6/032A61B17/1204A61B17/12136A61M16/0434A61M16/208A61B2017/00022A61M25/10A61M2016/003A61M2016/0027A61M2025/1052A61M2205/3303A61M2205/3334A61M2205/3344A61M2210/1035A61M2230/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,758,239
App. No.
15/358,483
Granted
Sep 1, 2020
Kind
B2
Abstract

The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.

Claims (18)

1. A system for detecting collateral ventilation into a lung compartment in a patient, said system comprising:

a catheter adapted to be introduced transtracheally to an airway leading to a target lung compartment, wherein the catheter comprises a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end;

an occlusion member on a distal region of the catheter, said occlusion member being adapted to selectively occlude the airway such that access to the compartment is provided only through the lumen of the catheter;

a one-way flow element adapted to be disposed within or in-line with the lumen so that flow in a distal-to-proximal direction is allowed and flow in a proximal-to-distal direction is inhibited or prevented;

a flow-measurement device connectable to the catheter, wherein the flow-measurement device is configured to measure air flow or accumulation from the catheter over time; and

a processor configured to detect collateral ventilation based on the measured air flow or accumulation from the catheter over time.

2. A system as in claim 1 , wherein the flow-measurement device comprises a slack collection bag.

3. A system for evaluating a target lung compartment comprising:

catheter positionable within a lung passageway leading to the target lung compartment, wherein the catheter comprises a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end;

an occlusion member on a distal region of the catheter configured to isolate the target lung compartment;

a one-way flow element adapted to be disposed within or in-line with the lumen so that flow in a distal-to-proximal direction is allowed and flow in a proximal-to-distal direction is inhibited or prevented;

at least one sensor which generates measurement data reflecting pressure within the target lung compartment; and

a processor which performs computations with the use of the measurement data reflecting pressure within the target lung compartment and is configured to detect collateral ventilation based upon said computations.

4. The system as in claim 3 , wherein the computations include calculating a degree of hyperinflation of the target lung compartment.

5. The system as in claim 3 , wherein the computations include calculating a state of compliance of the target lung compartment.

6. The system as in claim 3 , wherein the computation includes calculating collateral, resistance of the target lung compartment.

7. The system as in claim 3 , wherein the system is configured to generate a plurality of measurements of pressure over a predetermined time period.

8. The system as in claim 3 , wherein the system is configured to inject a compound into the target lung segment to block collateral flow channels.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: ALJURI, NIKOLAI; PERKINS, RODNEY C.; BEYHAN, NIYAZI
To: PULMONX
Reel/Frame 048643/0255 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Continuity (8)
Continuation 13938025 · Jul 9, 2013
Continuation 12820547 · Jun 22, 2010
Continuation In Part 11685008 · Mar 12, 2007
Continuation In Part 11296951 · Dec 7, 2005
Provisional Application 60645711 · Jan 20, 2005
Provisional Application 60696940 · Jul 5, 2005
Provisional Application 60699289 · Jul 13, 2005
Related Publication 20170071606A1 · Mar 16, 2017
Cited By (4)
US 12,350,428 US 12,471,800 US 12,521,064 US 12,629,051